Podcasts about national institutes

In his weekly clinical update, Dr. Griffin and Vincent Racaniello talk about the health misconceptions that RFK Jr continues to perpetuate and how to combat them, first cases of highly pathogenic influenza in the California elephant seal population before Dr. Griffin deep dives into economic costs of not vaccinating against measles, the measles outbreak in South Carolinaand Utah, ICE detention centers, lack of accurate reporting may prevent the US from losing its status as a country that eliminated measles, immune amnesia from measles infection, influenza strain selection for the 2026-2027 vaccine,  recent statistics for RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, where to find PEMGARDA, how to access and pay for Paxlovid, when to use steroids for treating influenza, long COVID treatment center, where to go for answers to your long COVID questions, clinical trials for long COVID treatment including GLP-1 inhibitors and IVIG and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Kristen Panthagani, MD, PhD (Substack) You can know things! (Substack) Kmpanthagani: Kristen Panthagani, MD, PhD Instagram) Kristen Panthagani, MD, PhD kmpanthagani (Threads) Psychological inoculation improves resilience against misinformation on social media (Science) 5 Logical fallacies in the era of RFK Jr. (Substack) Tecovirimat for the Treatment of Mpox (NEJM) California records avian flu in northern elephant seals (CIDRAP) First Cases of Highly Pathogenic Avian Influenza in Northern Elephant Seals Confirmed in California (UC Davis) Wastewater for measles (WasterWater Scan) The health and economic repercussions of declining MMR coverage in the United States (medRxiv) 2025 measles resurgence carries estimated $244 million price tag (CIDRAP) US builds case to retain measles elimination status as infections mount (Reuters) Expert meeting on US measles elimination status delayed to November (Reuters) 'Nearly Every' Child With Measles Suffers This Hidden Threat (Medscape) CDC acting director Bhattacharya urges use of measles vaccine (Reuters) Measles cases and outbreaks (CDC Rubeola) Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) Utah Measles Dashboard (Utah Department of Health and Human Services) Escobar: ICE sending sick migrants to El Paso hospitals for quarantine (BorderReport) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) RSV Detection and Antibiotic Prescribing Decisions for Pediatric Respiratory Tract Infections (JAMA Network) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID SARS-CoV-2Persistence and the Gut Microbiota: New Insights into Long COVID Pathogenesis (MDPI) Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19 (Annals of Internal Medicine) Long COVID: RECOVER-TLC Clinical Trials (Foundation for the National Institute of Health) Design and rationale of RECOVER-AUTONOMIC: A randomized platform trial evaluating interventions for Long COVID postural orthostatic tachycardia syndrome (American Heart Journal) Dr. Ruth's Newsletter: COVID, Flu & Health News, 3/1/26 (Substack) Reaching out to US house representative Letters read on TWiV 1302 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

In our latest episode, we ask a different question about mental health: What if anxiety and depression are signals, not just diagnoses? I'm joined by Dr. Peter Bongiorno, naturopathic doctor and functional medicine expert specializing in integrative mental health, to explore how inflammation, nutrient status, mitochondrial function, and gut health shape mood and behavior. We move beyond symptom suppression and into root cause investigation. Why are so many patients still struggling despite conventional care? What role do inflammation and blood-brain barrier integrity play? How does the gut-brain axis influence anxiety and depression? And why is sleep non-negotiable for mitochondrial repair and emotional resilience? Dr. Bongiorno breaks down the biological drivers of mental health, from nutrient deficiencies and hormonal shifts to neuroinflammation and vagal tone. We also discuss why lifestyle interventions often need to come before supplementation, and how functional psychology integrates physiology with emotional well-being. If you want a deeper understanding of how to approach mental health through the lens of systems biology, this conversation delivers clarity, practicality, and a roadmap forward.   Key takeaways: Natural Approaches to Mental Health: Discussing the growing traction of natural therapies, focusing on lifestyle, nutrition, and addressing biological imbalances. Nutrient Deficiencies and Mental Health: Exploring key nutrients such as vitamin D, B12, and magnesium, and their vital roles in neurotransmitter production and mood regulation. Importance of the Gut-Brain Axis: Highlighting how gut health impacts mental wellness through mechanisms involving microbiota and vagus nerve communication. Role of Sleep and Exercise: Addressing the essential contributions of restful sleep and physical activity to overall mental health, emphasizing the balance of mitochondrial function. Herbal and Supplementary Support: Assessing the effectiveness of supplements like St. John's Wort and saffron as supportive measures in managing depressive symptoms.   More About Dr. Peter Bongiorno:   Dr. Peter Bongiorno is on a mission to revolutionize psychiatric care by integrating effective holistic healing into mental health practice. Since 2004, his thriving practices in New York have transformed countless lives. A graduate of Bastyr University in Seattle, where he earned his naturopathic doctor degree in 2003 and served as class speaker, Dr. Bongiorno's journey began by researching as a pre-doctoral fellow at the National Institutes of Mental Health and Yale University's Department of Pharmacology. In 2008, Dr. Bongiorno authored the groundbreaking textbook Healing Depression published by CCNM Press – the first textbook on integrative medicine for depression, marking a significant milestone in the field. Since then, he has produced numerous influential papers, textbook chapters, and books, passionately educating the medical community on the most effective natural methods to heal mood disorders. His latest essential text, Holistic Solutions for Anxiety and Depression, is published by Norton. For the public, his books are Put Anxiety Behind You and How Come They're Happy and I'm Not?, which offer actionable insights into Dr. Bongiorno's effective methods for naturally overcoming anxiety and depression. His books have been translated into multiple languages, including Chinese and Italian. You can discover the transformative work of Dr. Bongiorno and join the movement toward natural mental health solutions at www.drpeterbongiorno.com. Website Instagram Connect with me! Website Instagram Facebook YouTube

She climbed Everest at 19 with no money, no permit, and no plan B. Krushnaa Patil is the youngest Indian woman to summit Mount Everest and one of only two Indians to attempt the Seven Summits — the seven highest peaks on seven continents. In this Women's Day Special episode of The xMonks Drive Podcast with Gaurav Arora, Krushnaa Patil shares her full story for the first time.From growing up trekking the Himalayas with her family to training as a classical dancer, from faking jaundice to sneak into a mountaineering course to fighting the Indian government, Bollywood celebrities, and a hostile expedition team just to raise ₹30 lakh for Everest — this is one of the most extraordinary journeys ever told on this podcast.Krushnaa Patil summited Everest on May 21, 2009 as part of the Eco Everest Expedition, becoming the youngest Indian woman to do so. She then completed the Seven Summits by climbing the highest peaks in Antarctica, South America, Europe, and Australia. But when she arrived at Denali — also known as Mount McKinley — in Alaska for her 7th and final summit, she was stopped 400 metres from the top and told she was the weakest member of the team. What happened next is a story of racism in mountaineering that she has never fully spoken about publicly.This episode covers:- Growing up in Pune and the Himalayas- Classical dance, yoga, Bharatanatyam and Kalari Payattu- NIM — the National Institute of Mountaineering, Uttarkashi- The Vice-Principal who told her to go to Bollywood- The Satopanth expedition and how she fought to be on it- The letter from a friend that destroyed her plan to climb Everest with NIM- Raising ₹30 lakh with zero connections — from Vilasrao Deshmukh to Aamir Khan- Her father's secret loan and how Saraswat Bank waived it after her Everest summit- The death of a Sherpa during the Eco Everest Expedition 2009- Climbing buddy Henry's breakdown at Camp Two on Everest- The lightning storm on summit night that echoed the 1996 Everest tragedy- Standing in the shadow of Everest at the South Summit- What Krushnaa Patil felt at the top of the world — shoonya- The racism in mountaineering she faced at Denali Mount McKinley- Why she considers the Seven Summits done and dusted anyway- What it really takes to climb Everest as a young Indian woman with no resourcesTimestamps:00:00 Everest First Impressions00:25 Setbacks And Doubts01:43 Rihanna And Big Dreams03:28 First Peaks And Destiny06:53 Getting On Satopanth11:04 Sickness And Team Role17:33 Betrayal Letter Fallout21:23 Raising Everest Funds26:54 Father Loan Twist36:40 Everest Summit Strategy38:50 Altitude Body Basics39:29 Death At Base Camp40:57 Buddy System Setup42:53 Henry Altitude Crisis45:35 Eco Everest And Spirits46:38 Oxygen And Summit Night48:45 Lightning And Ridge Lights53:34 South Summit Sunrise56:39 Summit Mindset Shift01:01:41 Descent Risks And Bodies01:04:26 Denali Summit Denied01:11:06 Racism Aftermath ClosingIf this episode moved you, please like, share and subscribe. Drop a comment below telling us what part of Krushnaa Patil's story hit you the hardest. And if you're watching this around Women's Day — share it with every woman in your life who needs to hear this story.

Our guest on The Voice Podcast is Congressman Paul Tonko, a Democrat who represents New York's 20th Congressional District. A longtime state Assembly member who was elected to Congress in 2008, Tonko has been a fighter for his constituents, for higher education and for organized labor. He's come out against the war in Iran, calling it reckless and unjustified. He's also called for the abolition of U.S. Immigrations and Customs Enforcement, citing the death and destruction the agency has caused under President Trump's cruel immigration crackdown and the fatal shootings of two Minneapolis protesters—both U.S. citizens—by federal agents. As the ranking member of the House Energy and Commerce Subcommittee on Environment, Tonko blasted the administration for its Feb. 12 decision to repeal the Environmental Protection Agency's “endangerment finding,” a long-standing, scientifically proven conclusion that greenhouse gases are dangerous to humans and the planet.He stood with United University Professions in our fight against the Trump administration's drastic 2025 cuts to federal research funding. In February 2025, Tonko joined with three other New York House Democrats to criticize the National Institutes of Health for drastically reducing grant funding for indirect costs. In our Lookback segment, Mike Lisi remembers the tragic Triangle Shirtwaist Factory Fire which took place on March 25, 1911 and the quirky, nearly two-month strike of San Francisco's KMPX-FM, America's first underground rock station, which started March 18, 1968. In Kowal's Coda, The Voice Podcast host Fred Kowal provides commentary on the war in Iran and why the this chaotic action - which came without a declaration of war by Congress - has occurred.  Links to music from this episode: Metropolitan Klesmer: "Die Fire Korbunes (The Fire's Sacrifices)" - https://www.youtube.com/watch?v=G6OP6GRkSNoAce of Cups: "Feel Good" -  https://www.youtube.com/watch?v=6KqPCFw-VHQ

This week, Enna chats with Dr. Casey Kenyon Brown, Professor at Georgetown University in the Department of Psychology and the Interdisciplinary Program in Neuroscience. She has received numerous honors and awards, including the prestigious Pathway to Independence Award from the National Institute on Aging and the Rising Star Award from the Association for Psychological Science.Casey's research examines how we share, understand, and influence one another's emotions. She's interested in how these interpersonal emotional processes are beneficial for healthy aging, and how these processes may go awry and contribute to depression. In this episode, Casey shares her journey in psychology, talks about her research on emotion and relationships, and provides advice on how we can build strong connections with people we love. Please join our substack (https://stanfordpsypod.substack.com/) to stay connected with our community of listeners from all over the world! If you found this episode interesting, please consider leaving us a good rating. It just takes a minute but will allow us to reach more listeners to share our love for psychology. Casey's Lab Website: https://careslab.facultysite.georgetown.edu/ Casey's Lab Twitter: @CARESlab_GUCasey's paper on empathy and shared depression: https://doi.org/10.1177/21677026221141852 Enna's LinkedIn: https://www.linkedin.com/in/ennayuxuanchen/ Enna's Twitter: @EnnaYuxuanChenPodcast Contact: stanfordpsychpodcast@gmail.com Podcast Twitter: @StanfordPsyPod

First up on the podcast, a peek into the roiling seas of U.S. science policy. ScienceInsider Editor Jocelyn Kaiser talks about shifting leadership at the National Science Foundation and the Centers for Disease Control and Prevention as well as a dip in funding rates by the National Institutes of Health. Staff Writer Robert F. Service covers proposed restrictions on access by international researchers and students to the National Institute of Standards and Technology. Contributing Correspondent Warren Cornwall talks about the Department of Energy's rush to loosen radiation exposure standards. Senior International Correspondent Richard Stone discusses why an accusation of nuclear weapons testing in China could spark a new round of weapons testing in the United States and Russia. Next on the show, this year's children's book roundup features everything from a look at space law to a clever wartime spider farmer. Senior Editor Valerie Thompson joins host Sarah Crespi to discuss the books and the reviews of them, written by Science staffers (and sometimes their kids). This week's episode was produced with help from Podigy. About the Science Podcast Learn more about your ad choices. Visit megaphone.fm/adchoices

Terence Kealey and Jeffrey Flier debate abolishing the National Institutes of Health.

Send a textWellness is a word we hear all the time—but what does it actually mean when life is complicated, busy, and sometimes overwhelming? In this milestone 200th episode, I explore the idea that living well isn't about perfection or rigid routines, but about the small choices we make every day that quietly shape our health, our relationships, and the direction of our lives. I invite you to reflect on the emotions you're choosing from, the responsibilities you're carrying, and the possibility that wellness might be closer than you think. If you've ever wondered how to care for yourself while managing a full and demanding life, this conversation might open a new perspective on what it truly means to live well.Quotes of the Week“Well-being is realized by small steps, but is truly no small thing.” — Zeno “The part can never be well unless the whole is well.” — Plato CitationsCohen, S., Janicki-Deverts, D., & Miller, G. E. (2012). Psychological stress and disease. JAMA.Lee, I. M., et al. (2019). Association of Step Volume and Intensity With All-Cause Mortality in Older Women. JAMA Internal Medicine.Waldinger, R., & Schulz, M. Harvard Study of Adult Development. Harvard Medical School.National Institutes of Health – Your Healthiest Self: Wellness Toolkits. Let's go, let's get it done. Get more information at: http://projectweightloss.org

In this bonus episode, Ross continues his conversation with Dr. J. Bhattacharya, Director of the National Institutes of Health and Interim Director of the CDC. They dive into the traditional role of the CDC and how it's been impacted by the pandemic. Dr. Bhattacharya shares his thoughts on the importance of the CDC's role in providing science-based advice and the need for humility in public health leadership. They also discuss the challenges of dealing with bad faith questions from reporters and the impact of fake news on the scientific community.See omnystudio.com/listener for privacy information.

In this episode, host Ross welcomes back Dr. Jay Bhattacharya, Director of the National Institutes of Health and interim Director of the Centers for Disease Control and Prevention. They dive into the importance of vaccination, particularly in the context of the current measles outbreak. Dr. Bhattacharya shares the official CDC position on childhood vaccines and the risks associated with not vaccinating. They also discuss the challenges of working in government, including navigating bureaucracy and building coalitions. The conversation touches on the role of the NIH and CDC in public health, and how their missions are often misunderstood.See omnystudio.com/listener for privacy information.

In this episode, Ross discusses the ongoing conflict with Iran, sharing his thoughts on the war's impact on the market and the US economy. He also talks about the recent Supreme Court ruling on President Trump's tariffs and the potential consequences for the administration. Additionally, Ross shares his concerns about the lack of vaccination in certain groups, leading to measles outbreaks in the US and other countries. He's joined by Dr. Jay Bhattacharya, the director of the National Institutes of Health and interim director of the CDC, to discuss the importance of vaccination and the CDC's recommendations.See omnystudio.com/listener for privacy information.

If you've ever wondered what a movie production designer actually does, our guest today describes it in the simplest terms: it is everything you see in the frame that isn't a costume. It turns out, production design has a lot in common with product design. Our guest is the visionary production designer Fiona Crombie. You've seen her work in incredible films like The Favourite, and most recently, in the hauntingly beautiful Hamnet. This film is currently taking the industry by storm with eight Academy Award nominations, including a nod for Fiona herself for Best Production Design. Trailer for Hamnet, nominated for 8 Academy Awards in including Fiona Crombie for production design From the sprawling architecture of a Tudor estate down to the specific curve of a spoon or the texture of a tablecloth, Fiona's job is to build a physical reality that reflects the interior lives of the characters on screen. In our conversation, we explore how production design shapes performance, how historical accuracy balances with storytelling, how a visual “mission statement” guides an entire crew, and what it means to create environments that carry grief, love, and memory. Bio Fiona Crombie is an Australian production designer, twice nominated for the Academy Award for Best Production Design — for The Favourite and Hamnet. Born in Adelaide and raised in Sydney, she trained at the National Institute of Dramatic Art (NIDA) before becoming the resident designer at the Sydney Theatre Company, where she developed the deep relationship with text and storytelling that still shapes her work today. *** Premium Episodes on Design Better This is a premium episode on Design Better. We release two premium episodes per month, along with two free episodes for everyone. New premium benefit: get a behind-the-scenes pass to every episode with The Roundup, where each week we bring you insights and actionable tactics from recent episodes. Premium subscribers get access to the documentary Design Disruptors and our growing library of books. You'll also get access to our monthly AMAs with former guests, ad-free episodes, discounts and early access to workshops, and our monthly newsletter The Brief that compiles salient insights, quotes, readings, and creative processes uncovered in the show. And subscribers at the annual level now get access to the Design Better Toolkit, which gets you major discounts and free access to tools and courses that will help you unlock new skills, make your workflow more efficient, and take your creativity further. Upgrade to paid

Send a textHow dangerous is loneliness to your health? In this clip from our episode “The Wellness Industry Is Misleading You”, host John Driscoll speaks with Zeke Emanuel about the data linking close friendships to longer life, including research showing significantly higher mortality among those with few close relationships.Listen to the full episode here

In episode 177 of Cybersecurity Where You Are, Tony Sager sits down with Bob Gendler, IT Specialist at the National Institute of Standards and Technology (NIST), and Edward Byrd, Senior Cybersecurity Engineer of the CIS Benchmarks® at the Center for Internet Security® (CIS®). Together, they use the open-source macOS Security Compliance Project to discuss the power of community-developed security content.Here are some highlights from our episode:01:15. Introductions to Bob and Edward along with their first Mac devices03:24. Why CIS Benchmarks are needed for macOS05:49. The need to make security guidance a collaborative, ongoing exercise11:06. Inside the expanding community supporting the macOS Security Compliance Project16:59. A practical win: making daily security operations easier to manage21:40. An operational feedback loop of improving the CIS Benchmarks25:25. The implications of compliance pointing to assurance, not security30:53. Advice on how to prepare for an audit using the CIS Benchmarks34:18. The importance of rationale in defining reasonable cybersecurity behavior35:30. A teaser of upcoming changes and how to get involvedResourcesCIS Benchmarks ListMapping and Compliance with the CIS BenchmarksApple macOSCIS WorkBenchCIS CommunitiesEpisode 156: How CIS Uses CIS Products and ServicesReasonable CybersecurityIf you have some feedback or an idea for an upcoming episode of Cybersecurity Where You Are, let us know by emailing podcast@cisecurity.org.

✨ Special Rerelease Episode ✨In this important conversation, Kayleigh sits down with Dr. Pria Alpern to talk about EMDR therapy and its powerful role in healing birth trauma. If you've ever felt stuck in intrusive memories, body flashbacks, or overwhelming anxiety after your birth experience, this episode offers both education and hope. We break down what EMDR actually is, how it works, and why it can be especially effective for perinatal trauma.In this episode, we talk about:

The episode centers on the federal government's evolving approach to AI vendor governance, underscored by the recent directive from President Donald Trump for federal agencies to halt the use of Anthropic's AI technology. This shift follows the Pentagon's termination of its relationship with Anthropic over the company's refusal to relax contract restrictions around citizen data and autonomous weapons, ultimately resulting in Anthropic being designated as a “supply chain risk” by Defense Secretary Pete Hegseth. For MSPs and IT providers serving federal and SLED clients, this designation functions as an immediate procurement barrier rather than a negotiable label, directly impacting vendor eligibility and contract continuity. Contextually, 70% of federal agencies are reassessing their use of AI tools amid fluid regulations and heightened concerns around transparency and accountability, according to recent reports. The National Institute of Standards and Technology (NIST) has launched the AI Agent Standards Initiative, but enforcement is several years away, with only a request for information planned by March 2026. In parallel, a diplomatic initiative led by Secretary of State Marco Rubio opposes international regulations on foreign data handling, though this stance does not supersede foreign law, creating a complex compliance landscape, especially for multinationals. Meanwhile, the U.S. Supreme Court's refusal to hear an AI copyright case reaffirms the lack of copyright protection for purely AI-generated works. The episode also discusses OpenAI's agreement with the Pentagon, described by CEO Sam Altman as "rushed," and criticized for permitting domestic surveillance under flexible legal interpretations. Public and employee backlash prompted OpenAI to revise contract terms, but critics argue essential permission structures remain. Anthropic's rollout of an AI migration feature during this period is flagged as a compliance event, raising risk when transferring data histories across vendor boundaries without audit or logging. Notably, consumer responses to AI vendor practices—evidenced by surges in Claude signups and ChatGPT uninstalls—are now influencing enterprise technology procurement as values-based purchasing enters the operational conversation for service providers. Operationally, the lack of a stable legislative or regulatory framework means MSPs and their clients face rapidly shifting governance through contract terms and procurement policy rather than law. The episode cautions that vendor selection cannot be guided by assumptions of ethical safeguards in provider policies or by default transitions to alternative vendors such as OpenAI, whose legal standing remains unsettled. Key recommendations include auditing client environments for exposure to designated supply chain risks, refraining from rigid vendor integrations, updating contractual IP language in light of the absence of AI copyright, and maintaining ongoing awareness of governance developments. Multi-vendor strategies and adaptable compliance positions are identified as essential risk mitigation practices in an environment marked by administrative fiat and reactive vendor positions. Three things to know today 00:00 Anthropic Blacklisted After Rejecting Pentagon's Autonomous Weapons Data Demands 04:58 OpenAI Wins Federal AI Contract Anthropic Refused, Then Rewrites It Under Pressure 07:38 Anthropic Outages Hit as Claude Sign-Ups Quadruple, ChatGPT Uninstalls Surge 295% Supported by: ScalePadSmall Biz Thoughts Community  

We're joined by Nick Nanos, chief supply chain officer and SVP of wholesale at the Liquor Control Board of Ontario (LCBO), an organisation on the frontline of navigating tariffs, labour disruption and complex global logistics. Hear how his team is spearheading change and innovation in practice to become the strategic lever the  crown agency now relies on to respond to challenges and consistently deliver value. Nick reflects on the qualities required of procurement and supply chain leaders amidst today's volatility. And, as a member and advocate for both the National Institute of Supply Chain Leaders (NISCL) and CIPS, the role he feels professional bodies play in developing those skills. Related links:  Discover more about the National Institute of Supply Chain Leaders (NISCL) Find out how you can achieve NISCL-CSCL and MCIPS dual designation and what it can do for you About the Liquor Control Board of Ontario

Our Deputy Head of Global Research Michael Zezas and Stephen Byrd, Global Head of Thematic and Sustainability Research, discuss how the U.S. is positioning AI as a pillar of geopolitical influence and what that means for nations and investors.Read more insights from Morgan Stanley.----- Transcript -----Michael Zezas: Welcome to Thoughts on the Market. I'm Michael Zezas, Morgan Stanley's Deputy Head of Global Research.Stephen Byrd: And I'm Stephen Byrd, Global Head of Thematic and Sustainability Research.Michael Zezas: Today – is AI becoming the new anchor of geopolitical power?It's Wednesday, February 27th at noon in New York.So, Stephen, at the recent India AI Impact Summit, the U.S. laid out a vision to promote global AI adoption built around what it calls “real AI sovereignty.” Or strategic autonomy through integration with the American AI stack. But several nations from the global south and possibly parts of Europe – they appear skeptical of dependence on proprietary systems, citing concerns about control, explainability, and data ownership. And it appears that stake isn't just technology policy. It's the future structure of global power, economic stratification, and whether sovereign nations can realistically build competitive alternatives outside the U.S. and China.So, Stephen, you were there and you've been describing a growing chasm in the AI world in terms of access to strategies between the U.S. and much of the global south, and possibly Europe. So, from what you heard at the summit, what are the core points of disagreement driving that divide?Stephen Byrd: There definitely are areas of agreement; and we've seen a couple of high-profile agreements reached between the U.S. government and the Indian government just in the last several days. So there certainly is a lot of overlap. I point to the Pax Silica agreement that's so important to secure supply chains, to secure access to AI technology. I think the focus, for example, for India is, as you said; it is, you know, explainability, open access. I was really struck by Prime Minister Modi's focus on ensuring that all Indians have access to AI tools that can help them in their everyday life.You know, a really tangible example that really stuck with me is – someone in a remote village in India who has a medical condition and there's no doctor or nurse nearby using AI to, you know, take a photo of the condition, receive diagnosis, receive support, figure out what the next steps should be. That's very powerful. So, I'd say, open access explainability is very important.Now, the American hyperscalers are very much trying to serve the Indian market and serve the objectives really of the Indian government. And so, there are versions of their models that are open weights, that are being made freely available for health agencies in India, as an example; to the Indian government, as an example.So, there is an attempt to really serve a number of objectives, but I think this key is around open access, explainability, that I do see that there's a tension.Michael Zezas: So, let's talk about that a little bit more. Because it seems one of the concerns raised is this idea of being captive within proprietary Large Language Models. And maybe that includes the risk of having to pay more over time or losing control of citizen data. But, at the same time, you've described that there are some real benefits to AI that these countries want to adopt.So, what is effectively the tension between being captive to a model or the trade off instead for pursuing open and free models? Is it that there's a major quality difference? And is that trade off acceptable?Stephen Byrd: See, that's what's so fascinating, Mike, is, you know, what we need to be thinking about is not just where the technology is today, but where is it in six months, 12 months, 24 months? And from my perspective, it's very clear. That the proprietary American models are going to be much, much more capable.So, let's put some numbers around that. The big five American firms have assembled about 10 times the compute to train their current LLMs compared to their prior LLMs, and that's a big deal. If the scaling laws hold, then a 10x increase in training compute to result in models are about twice as capable.Now just let that sink in for a minute, twice as capable from here. That's a big deal. And so, when we think about the benefit of deploying these models, whether it's in the life sciences or any number of other disciplines, those benefits could start to get very large. And the challenge for the open models will be – will they be able to keep up in terms of access to compute, to training, access to data to train those models? That's a big question.Now, again, there's room for both approaches and it's very possible for the Indian government to continue to experiment and really see which approach is going to serve their citizens the best. And I was really struck by just how focused the Indian government is on serving all of their citizens. Most notably, you know, the poorest of the poor in their nation. So, we'll just have to see.But the pure technologist would say that these proprietary models are going to be increasing capability much faster than the open-source models.So, Mike, let's pivot from the technology layer to the geopolitical layer because the U.S. strategy unveiled at the summit goes way beyond innovation.Michael Zezas: Yeah, it's a good point. And within this discussion of whether or not other countries will choose to pursue open models or more closely adhere to U.S. based models is really a question about how the United States exercises power globally and how it creates alliances going forward.Clearly some part of the strategy is that the U.S. assumes that if it has technology that's alluring to its partners, that they'll want to align with the U.S.' broad goals globally. And that they'll want to be partners in supporting those goals, which of course are tied to AI development.So, the Pax Silica [agreement], which you mentioned earlier, is an interesting point here because this is clearly part of the U.S. strategy to develop relationships with other countries – such that the other countries get access to U.S. models and access to U.S. AI in general. And what the U.S. gets in return is access to supply chain, critical resources, labor, all the things that you need to further the AI build out. Particularly as the U.S. is trying to disassociate more and more from China, and the resources that China might have been able to bring to bear in an AI build out.Stephen Byrd: So, Mike, the U.S. framed “real AI sovereignty” as strategic autonomy rather than full self-sufficiency. So, essentially the. U.S. is encouraging nations to integrate components of the American AI stack. Now, from your perspective, Mike, from a macro and policy standpoint, how significant is that distinction?Michael Zezas: Well, I think it's extremely important. And clearly the U.S. views its AI strategy as not just economic strategy, but national security strategy.There are maybe some analogs to how the U.S. has been able to, over the past 80 years or so, use its dominance in military and military equipment to create a security umbrella that other countries want to be under. And do something similar with AI, which is if there is dominant technology and others want access to it for the societal or economic benefits, then that is going to help when you're negotiating with those countries on other things that you value – whether it be trade policy, foreign policy, sanctions versus another country. That type of thing.So, in a lot of ways, it seems like the U.S. is talking about AI and developing AI as an anchor asset to its power, in a way that military power has been that anchor asset for much of the post World War II period.Stephen Byrd: See, that's what's so interesting, Mike, [be]cause you've highlighted before to me that you believe AI could replace weaponry as really the anchor asset for U.S. global power. Almost a tech equivalent of a defense umbrella.So how durable is that strategy, especially given that some countries are expressing unease about dependency?Michael Zezas: Yeah, it's really hard to know, and I think the tension you and I talked about earlier, Stephen, about whether countries will be willing to make the trade off for access to superior AI models versus open and free models that might be inferior, that'll tell us if this is a viable strategy or not. And it appears like this is still playing out because, correct me if I'm wrong, it's not like we've received some very clear signals from India or other countries about their willingness to make that trade off.Stephen Byrd: No, I think that's right. And just building on the concept of the trade-offs and, sort of, the standard for AI deployment, you know, the U.S. has explicitly rejected centralized global AI governance in favor of national control aligned with domestic values.So, what does that signal about how global technology standards may evolve, particularly as in the U.S., the National Institute of Standards and Technology, or NIST, works to develop interoperable standards for agentic AI systems.Michael Zezas: Yeah, Stephen, I think it's hard to know. It might be that the U.S. is okay with other countries having substantial degrees of freedom with how they use U.S.-based AI models because they could use U.S. law to, at a later date, change how those models are being used – if there's a use case that comes out of it that they find is against U.S. values. Similar in some way to how the U.S. dollar being the predominant currency and, therefore, being the predominant payment system globally, gives the U.S. degrees of freedom to impose sanctions and limit other types of economic transactions when it's in the U.S. interest.So, I don't know that to be specifically true, but it's an interesting question to consider and a potential motivation behind why a laissez-faire approach might be, ultimately, still aligned with U.S. interests.Stephen Byrd: So, Michael, it sounds like really AI is becoming the new strategic infrastructure globally.Michael Zezas: Yeah, I think that's actually a great way to think about it. And so, Stephen, if that were the case, and we're talking about the potential for this to shape geopolitical competition, potentially economic differentials across the globe. And if that is correlated, at least, to some degree with the further development and computing power of these models, what do you think investors should be looking at for signals from here?Stephen Byrd: Number one, by a mile for me, is really the pace of model progress. Not just American models, but Chinese models, open-source models. And there the big reveal for the United States should be somewhere between April and June – for the big five LLM players. That's a bit of speculation based on tracking their chip purchases, their power access, et cetera. But that appears to be the timeframe and a couple of execs have spoken to that approximate timeframe.I would caution investors that I think we're going to be surprised in terms of just how powerful those models are. And we're already seeing in early 2026, these models that were not trained on that kind of volume of compute have really exceeded expectations, you know, quite dramatically in some cases. And I'll give you one example.METR is a third-party that tracks the complexity, what these models can do. And METR has been highlining that every seven months, the complexity of what these models are able to do approximately doubles. It's very fast. But what really got my attention was about a week ago, one of the LLMs broke that trend in a big way to the upside.So, if the scaling laws would hold, based on what METR would've expected, they would expect a model to be able to act independently for about eight hours, a little over eight hours. And what we saw was, the best American model that was recently introduced was more like 15. That's a big deal. And so, I think we're seeing signs of non-linear improvement.We're also going to see additional statements from these AI execs around recursive self-improvement of the models. One ex-AI executive spoke to that. Another LLM exec spoke to that recently as well. So, we're starting to see an acceleration. That means we then need to really consider the trade-offs between the open models and the proprietary. That's going to become really critical and that should happen really through the spring and summer.Michael Zezas: Got it. Well, Stephen, thanks for taking the time to talk.Stephen Byrd: Great speaking with you, Mike.Michael Zezas: And thanks for listening. If you enjoy Thoughts on the Market, please leave us a review wherever you listen. And share the podcast with a friend or colleague today.

Obesity is a big problem in the US. The National Institute of Diabetes and Digestive and Kidney Diseases says 2 out of every 5 American adults are obese. What's more, one in three is overweight, with only about 25 percent of us at a healthy weight. It's not just adults; children are increasingly suffering weight […]

Send a textThe wellness industry is booming, but is it actually helping people live better lives? With trillions spent on supplements, special diets, and longevity hacks, it raises a bigger question about what really matters for long-term health.Dr. Zeke Emanuel, Author, Eat Your Ice Cream joins CareTalk to discuss the wellness industrial complex, the health risks of loneliness, and why social connection, simple habits, and even ice cream may matter more than expensive longevity obsessions.

Dr. Roger McFillin argues that Western allopathic medicine and psychiatry have medicalized normal human suffering by reducing emotions to biological or chemical reactions, turning symptom checklists into fixed identities, and sustaining a drug-driven "sick care" system that creates lifelong customers. He contrasts this with viewing emotions as powerful energy meant to be moved into creation and transformation, cites psychoneuroimmunology, and warns that suppressing fear and distress with pharmaceuticals can worsen long-term outcomes. The conversation covers exposure-based approaches to unlearn fear, the role of media, social media, and advertising in provoking fear and keeping people in an unconscious "drift" state, and the importance of intentional stillness, solitude (distinct from loneliness), prayer or silent meditation, and reducing phone use—especially at the start of the day—to become more conscious and intentional.    McFillin discusses how diagnostic labels like depression and anxiety shape identity, limit choices, and contribute to chronicity and polypharmacy. He contrasts PTSD with post-traumatic growth, emphasizing processing trauma memories, facing avoided situations, challenging overgeneralized threat beliefs, and practicing forgiveness and self-compassion while also taking ownership where appropriate. They also discuss the perceived harms of the "toxic masculinity" concept, men's wellbeing, the loss of wise elders, and how men often bond and cope through shared activities. Dr. Roger McFillin is a clinical psychologist and trauma recovery expert who challenges the medicalization of normal human emotions. With a focus on emotional resilience and personal growth, he specializes in exposure therapy and psychoneuroimmunology, exploring the connection between mind, emotions, and immune health. Dr. McFillin advocates for self-regulation and transforming emotional energy into healing, critiquing the overuse of pharmaceuticals in modern mental health treatment. Through his Substack, Radically Genuine, and podcast, Dr. McFillin educates individuals on overcoming fear, achieving stillness, and reconnecting with their true selves. His work empowers people to shift from a victim mindset to one of active growth, using trauma as a catalyst for resilience and positive change.   Science & Medicine   Psychoneuroimmunology   Overview & science (NIH): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130991/   Exposure Therapy   Wikipedia overview: https://en.wikipedia.org/wiki/Exposure_therapy   Cleveland Clinic explanation: https://my.clevelandclinic.org/health/treatments/25067-exposure-therapy   Anxiety & OCD exposure-based approaches (IOCDF): https://iocdf.org/about-ocd/treatment/erp/   Heart Coherence   HeartMath Institute overview: https://www.heartmath.org/heart-coherence/   Psychiatric Diagnosis & DSM   Critique of DSM and diagnostic categories: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195174/   Psychiatric diagnosis controversies: https://www.apa.org/monitor/2013/04/diagnosis   Psychology & Healing   Post-Traumatic Growth vs. PTSD   Scientific overview of post-traumatic growth: https://www.apa.org/monitor/2014/01/psychological-recovery   Journal article on PTG vs PTSD: https://www.sciencedirect.com/science/article/abs/pii/S0272735814000412   Forgiveness and Healing   Psychology Today on forgiveness: https://www.psychologytoday.com/us/basics/forgiveness   Research evidence on forgiveness and wellbeing: https://journals.sagepub.com/doi/10.1177/1745691614568356   Self‑Healing Practices   Grounding / Earthing   What is grounding/earthing? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378297/   PEMF (Pulsed Electromagnetic Field) Therapy   Basics of PEMF therapy: https://www.health.harvard.edu/pain/pulsed-electromagnetic-field-therapy   Meditation & Stillness   Mindfulness & stillness research: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422583/   Psychology Today on solitude and healing: https://www.psychologytoday.com/us/blog/hide-and-seek/201209/finding-solitude-its-benefits-and-challenges   Cultural & Media Influence   Mind Control & Fear Provocation   The psychology of fear in media messaging: https://www.frontiersin.org/articles/10.3389/fpsyg.2020.566245/full   Media influence and persuasion research: https://www.communicationtheory.org/agenda-setting-theory/   Toxic Masculinity   Research overview on toxic masculinity: https://www.apa.org/advocacy/health-men/guidelines   What toxic masculinity means: https://www.psychologytoday.com/us/blog/the-masculine-mind/201802/what-toxic-masculinity   Dr. Roger McFillin Content   Substack (Radically Genuine): https://drmcmillan.substack.com   Show Notes 00:00 Emotions as Energy 00:33 Medicalizing Suffering 02:44 Exposure Beats Suppression 05:18 Fear and Mind Control 10:21 Stillness vs Loneliness 14:47 Simple Stillness Practices 20:12 Morning Intention Rituals 25:56 Labels and Identity Traps 31:26 Systemic Treatment Harm 32:53 Depression Label Identity 35:08 Sadness Versus Pathology 36:10 PTSD And Growth 38:24 Processing Trauma Fully 41:44 Practical Recovery Steps 45:48 Forgiveness And Ownership 50:37 Toxic Masculinity Debate 56:12 Men Friendship And Elders 01:01:05 Closing Plugs Farewell 38:24 How PTSD Develops 41:44 Practical Trauma Recovery 45:48 Forgiveness and Ownership 50:37 Toxic Masculinity Debate 56:12 Male Friendship and Elders 01:01:05 Closing and Where to Follow   The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to cutting through the noise and uncovering the most effective strategies for optimizing health, longevity, and peak performance. This podcast dives deep into evidence-based approaches to hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise protocols, leveraging sunlight, and de-prescribing pharmaceuticals — using medications only when absolutely necessary. Beyond health science, we explore the intersection of public health and politics, exposing how policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being. Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen). If you're ready to take control of your health and performance, this podcast is for you.We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect with Dr. Mike Hart Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart

This week on the podcast, AgingIN CEO, Susan Ryan, welcomes Kelly Tremblay, PhD, a neuroscientist, World Health Organization advisor, NIH grant reviewer, advocate, and professor. As a first-generation college student, Kelly's path was shaped by lived experience. Growing up with a father who had multiple sclerosis, she became an early advocate for accessibility and healthcare equity. At the University of Washington, Kelly led research focused on the aging brain and collaborated with the National Institutes of Health and the World Health Organization to help translate science into global health strategies. In this wide-ranging conversation, Susan and Kelly discuss health literacy and Kelly's desire to bridge the gap between research and real life by making science accessible, practical, and actionable. This goal comes to life in the launch of Brain Bytes, a new monthly micro-cast debuting Friday, Feb. 27, with new episodes dropping on the fourth Friday of each month. Designed to deliver bite-sized, evidence-based insights, Brain Bytes will focus on six key areas of brain health: nutrition, hearing loss, vision loss, mood, cognition, and balance Throughout the episode, Kelly reminds us that knowledge is power—but only if it's accessible. Brain Bytes aims to empower listeners with clear, plain-language information that supports better decisions, stronger advocacy, and healthier aging.

Many Hawaii agriculture producers we speak with feel stressed and a bit confused by the workings of politics and the bills in the legislature. They want to see important changes happen, but are unclear what agriculture-related bills may be in session, or how individuals can be more involved to help things change. In this episode we speak with Hunter Heaivilin, Hawaii Farmers Union's Advocacy Director and founder of Supersistence to try to get a handle on the state of things in early 2026 and what folks can do to help impact the changes they want to see.Brought to you by University of Hawaii College of Tropical Ag. and Human Resilience (CTAHR), and the Seeds of Well-being (SOW) Project. This podcast is supported by the Farm and Ranch Stress Assistance Network (FRSAN) grant from the U.S. Department of Agriculture, National Institute of Food and Agriculture and Hawaii Department of Agriculture.Resources:SupersistenceHawaii Farmers Union United (HFU) Hawaii agriculture bill tracking and legislative progressNational Healthy Soils Policy NetworkOur podcast with NRCSOur podcast with Hawaii Ulu Co-opFind out more about us: Seeds Of Wellbeing website Seeds of Wellbeing Resource Hub All the SOW links

In this episode, Dr. Phil Mintz, Director of NC State University Industry Extension Services, talks with Bogdan Ionescu, co-owner of OGC Stained Glass (Ordway Glass Company), a husband-and-wife–run stained glass studio based in Fuquay-Varina, North Carolina. Bogdan walks us through how he and his wife Nicole built a thriving, award-winning business out of their garage—balancing art, family life, and purpose along the way. OGC Stained Glass was named the 2025 winner of the North Carolina Chamber's “Coolest Thing Made in North Carolina,” a remarkable achievement for a two-person operation focused entirely on hand-cut, one-of-a-kind stained glass art. This episode offers an honest and inspiring look at what it takes to build something meaningful—one piece of glass at a time. LINKS NCMEP | IES | Ordway Glass Company About the Guest Bogdan Ionescu is the co-owner of OGC Stained Glass, located in Fuquay-Varina, NC, alongside his wife Nicole—the primary artist behind the glass. Together, they create contemporary and traditional stained glass works that preserve heritage while pushing the craft forward.

Eli Lilly notches another win over Novo Nordisk, as Zepbound bests CagriSema in a head-to-head trial sponsored by Novo; The FDA kicked off Rare Disease Week, providing draft guidance on its new plausible mechanism pathway, while a bipartisan senate hearing on Thursday will focus on the authorization process for rare conditions; Another leadership change shakes up CDC; and Gilead acquires CAR T partner Arcellx for nearly $8 billion.  Everything is coming up Lilly. The Indianapolis-based pharma bested its chief rival, Novo Nordisk in a head-to-head test. In a Phase 3 trial initiated by Novo itself, Lilly's Zepbound generated 25.5% weight loss while the Danish pharma's CagriSema elicited 23%. The results sent Novo's shares plummeting by an unprecedented 20% to a pre-Wegovy valuation while Lilly's market cap continues to climb.   Novo attempted a comeback on Tuesday, announcing that its triple-G agonist UBT251 scored almost 20% weight loss after 24 weeks in a Phase 2 trial in China. By comparison, Lilly's own triple-G competitor retatrutide led to 17.5% weight loss over the same timeframe, according to BMO Capital Markets analysts. Novo also sweetened the pot, announcing that it would slash the prices for all three of its GLP-1 medicines starting in 2027.    Meanwhile, the FDA kicked off Rare Disease Week with draft guidance on the new Plausible Mechanism Pathway for personalized therapies that was first teased in November. Jumping off last summer's Baby KJ success story, the new pathway is aimed at advancing treatments for ultra-rare diseases. And a bipartisan senate hearing on Thursday will focus on the authorization process for rare disease therapies.  While the rare disease space has enjoyed recent regulatory progress, funding these vital therapies remains a challenge. Companies like the Orphan Therapeutics Accelerator (OTXL), a non-profit biotech, are trying to change this with creative approaches including tax exempt status and unique partnerships with CDMOs and CMOs. Finally, in a move that also has implication for the rare disease space, the FDA's official pivot from a two clinical trial requirement to just one for new drug applications is lighting up biopharma social media.   And over at the CDC, there is more upheaval on the leadership front as National Institutes of Health Director Jay Bhattacharya replaces acting director Jim O'Neill as head of the agency, and principal deputy director Ralph Abraham steps down, citing “unforeseen family obligations.”    On the business front, Gilead inked the biggest M&A deal of the year so far, acquiring CAR T partner Arcellx for nearly $8B. And Merck's Keytruda should have a few extra years of dominance thanks to a web of patents, with billions on the line. Check it out in BioPharm Executive, in your inboxes Wednesday.  HostsJef Akst, Managing Editor, BioSpaceHeather McKenzie, Senior Editor, BioSpaceAnnalee Armstrong, Senior Editor, BioSpace

Curtis and Jim examine the recent Trump administration revelation about alleged nuclear weapons testing by China and assess the strategic implications of the pronouncement and the testing for global deterrence and stability. They unpack the evolution of China's nuclear program and explain why understanding that history is essential to assessing its ambitions today. The discussion highlights the critical role of monitoring and detection systems, explores the political and international ramifications of renewed testing, and underscores the need for greater public awareness of national security threats, emphasizing the deep interconnection between science, strategy, and policy in sustaining effective nuclear deterrence in an increasingly complex global environment. https://www.hudson.org/events/assistant-secretary-state-christopher-yeaw-end-new-start-treatyThe views expressed are those of the host(s) and guest(s) alone and do not necessarily reflect those of the National Institute for Deterrence Studies, its members, or its components. References to commercial products, services, hyperlinks, or visual materials do not constitute endorsement.Get Involved with more NIDS Services: https://thinkdeterrence.com/Deterrence Education at NIDS https://thinkdeterrence.com/deterrence-education/ Listen to our Podcasts NIDS Podcast Network - National Institute for Deterrence Studies Like and follow us –The NIDS View: https://media.rss.com/nuclearview/feed.xmlLinkedIn: https://www.linkedin.com/company/thinkdeterrence X.com: https://x.com/thinkdeterrence YouTube: https://www.youtube.com/channel/UCyGa4dcPqONWzjmbuZMOBHQ Rumble: https://rumble.com/user/NIDSthinkdeterrence Global Security Review: https://globalsecurityreview.comOur Free Events: https://thinkdeterrence.com/events/

In this episode of Get Plugged In – AI Insights, Dale Hall (Managing Director, Society of Actuaries Research Institute) sits down with Ronald Poon Affat, Independent Board Director & Cross-Continental Actuary, joining live from São Paulo, Brazil, to explore how NIST is shaping the standards that will define trustworthy AI—and why that matters for actuaries. They discuss what the NIST AI Consortium is, why the SOA is actively contributing through its AI Safety Working Group, and what it's like collaborating with leading voices across technology, academia, and public policy. The conversation also dives into the next major focus area: TEVV (Testing, Evaluation, Verification, and Validation)—a practical "quality assurance" approach to ensure AI models are fair, explainable, reliable, and ready for regulatory scrutiny. Listen in for a clear, actuarial lens on where AI governance is headed in insurance—and how actuaries can lead by asking the right risk questions.

Colonel Derek “Kiwi” Williams joins NucleCast for a wide‑ranging discussion on the evolving nuclear landscape and what it means for global security. Together, they examine recent developments in nuclear testing, including China's reported testing activities and the use of decoupling techniques, and assess their implications for strategic stability.The conversation also explores the consequences of the expiration of the New START treaty, debating whether the future points toward renewed arms control frameworks or an emerging arms race. Host Adam Lowther and Williams dive into the role of hydro nuclear testing and stockpile stewardship in maintaining confidence in nuclear forces, as well as why a credible nuclear deterrent remains central to national security.Throughout the episode, they unpack the enduring importance of the nuclear triad, the challenges of nuclear proliferation, and how deterrence strategies must adapt in an increasingly competitive strategic environment.Colonel Derek “Kiwi” Williams is a strategic planner in the Plans and Policy Directorate at U.S. Strategic Command. A U.S. Air Force Weapons School graduate, he has extensive experience in bomber operations, nuclear planning, and deterrence strategy, including leadership roles at Air Force Global Strike Command, the Air Staff, and as Director of Operations for the 23d Bomb Squadron. He is the founder of the School of Advanced Nuclear Deterrence Studies, a former Air Force Fellow at Sandia National Laboratories, and a fellow at the National Institute for Deterrence Studies. Colonel Williams holds advanced degrees in defense and strategic studies and aerospace engineering, with additional certifications in nuclear weapons policy, effects, and operations.Episode Correction: NNSA does Hydrodynamic experiments (weapon representative geometries) LLNL's Contained Firing Facility (CFF).Socials:Follow on Twitter at @NucleCastFollow on LinkedIn: https://linkedin.com/company/nuclecastpodcastSubscribe RSS Feed: https://rss.com/podcasts/nuclecast-podcast/Rate: https://podcasts.apple.com/us/podcast/nuclecast/id1644921278Email comments and topic/guest suggestions to NucleCast@anwadeter.org

The National Institutes of Health continued to lean into the use of artificial intelligence last year. The NIH has now initiated more than 100 AI pilots over the last few years. Those efforts ramped up as the health agency also navigated staffing cuts and other turmoil in 20-25. For more, Federal News Network's Justin Doubleday joins me now.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

February is Heart Health Month, and in this episode of Making Shift Happen, we're breaking down how busy gravel cyclists and mountain bikers can build a stronger heart, without adding more stress to your schedule. Backed by research from the National Heart, Lung, and Blood Institute (NHLBI) and the National Institutes of Health (NIH), this episode covers practical, science-supported habits that improve cardiovascular health and cycling performance. You'll learn how to: Improve heart health through smart training and daily movement Fuel your body with simple, heart-healthy meals Use sleep and recovery to boost endurance and power Manage stress for better performance and long-term health Understand why knowing your health numbers matters Whether you're juggling work, family, and training – or just trying to ride stronger without burnout – this episode gives you realistic tools to support your heart, body, and mindset. Check out these other relevant episodes: 236. How to Stay Motivated When Winter Days Get Short and Cold 231. How to Maintain Bike Fitness Without Losing Motivation this Winter 196. 5 Nutrition and Fitness Tips for Winter    Do you have nutrition and fitness goals? I’m your coach!  If you’re ready to finally make some sustainable progress, feel strong and powerful on every climb uphill, feel less pain, perform better, or lose a few extra pounds, then apply to work with me by clicking here. I work with people just like you, and you’ll see results a helluva lot faster than on your own. #ShredStrong: Our Month Starts on Monday, March 2, 2026! #ShredStrong is my year-round strength training program for mountain bikers and gravel cyclists. You can join any time you want, but why not now?! Learn more about the program and sign-up HERE!  Keywords: heart health for cyclists, gravel cycling training, mountain bike fitness, endurance athlete heart health, cycling nutrition, cycling recovery, busy athlete training, cardiovascular health cycling, Shred Strong podcast

Eight skiers have been found dead, and one is still missing, a day after an avalanche hit the Sierra Nevada near Lake Tahoe. The sheriff's office says six survivors were rescued with “various injuries,” two of whom were transported to the hospital for treatment.In the largest military buildup yet in the Middle East, President Donald Trump is sending the USS Gerald R. Ford to the Mediterranean, along with a large fleet of fighter jets and aerial refueling tankers. This comes as negotiations between the United States and Iran continue, with Trump making his demands clear to the Iranian regime—no nuclear weapons and stop killing anti-regime protesters.The director of the National Institutes of Health is taking on an additional role. According to the White House on Wednesday, Dr. Jay Bhattacharya will serve as acting director of the CDC until a permanent nominee is confirmed.

This episode explores tadalafil (Cialis) as a potential longevity drug, though no randomized human trials prove it extends lifespan. Cialis works by blocking PDE5, enhancing nitric oxide signaling, and improving blood flow through vasodilation. Originally approved for pulmonary hypertension, it's also used for erectile dysfunction and BPH. Its 36-hour half-life makes it superior to Viagra for continuous longevity effects.   The host frames vascular aging and endothelial dysfunction as key drivers of age-related diseases (heart disease, stroke, dementia, kidney disease). Observational data shows Cialis users have 44% lower mortality, fewer cardiovascular events, reduced dementia risk, and lower mortality in diabetics. Additional benefits include improved cardiac function, reduced infarct size, arrhythmia suppression, and regression of left ventricular hypertrophy. A 2024 meta-analysis found it lowers hemoglobin A1C, possibly via improved microvascular perfusion, insulin sensitivity, and mitochondrial function.   Cialis crosses the blood-brain barrier and may improve neurovascular coupling and hippocampal plasticity, potentially benefiting those with or at risk of dementia. Safety is generally good with long-term daily use (2.5–5 mg), though cautions include avoiding use with nitrates, low blood pressure, or certain retinal disorders. Common side effects are headache, nasal congestion, and acid reflux. The host recommends consulting a doctor and references potential synergy with telmisartan.   Tadalafil (Cialis) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a604008.html](https://medlineplus.gov/druginfo/meds/a604008.html) Sildenafil (Viagra) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a699015.html](https://medlineplus.gov/druginfo/meds/a699015.html)   Key mechanisms mentioned Nitric Oxide (NO) — NCBI Bookshelf: [https://www.ncbi.nlm.nih.gov/books/NBK554485/](https://www.ncbi.nlm.nih.gov/books/NBK554485/) Cyclic GMP (cGMP) — NCBI Bookshelf: [https://www.ncbi.nlm.nih.gov/books/NBK542234/](https://www.ncbi.nlm.nih.gov/books/NBK542234/)   Conditions mentioned in the episode Benign Prostatic Hyperplasia (BPH) — MedlinePlus: [https://medlineplus.gov/benignprostatichyperplasia.html](https://medlineplus.gov/benignprostatichyperplasia.html) Pulmonary Arterial Hypertension (PAH) — MedlinePlus: [https://medlineplus.gov/pulmonaryhypertension.html](https://medlineplus.gov/pulmonaryhypertension.html)   Blood pressure drug mentioned Telmisartan — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a601249.html](https://medlineplus.gov/druginfo/meds/a601249.html)   Other longevity / comparison drugs mentioned Metformin — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a696005.html](https://medlineplus.gov/druginfo/meds/a696005.html) Sirolimus (Rapamycin) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a602026.html](https://medlineplus.gov/druginfo/meds/a602026.html)   Side-effect helper mentioned Ibuprofen (Advil) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a682159.html](https://medlineplus.gov/druginfo/meds/a682159.html)   Dementia meds mentioned Donepezil (Aricept) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a697032.html](https://medlineplus.gov/druginfo/meds/a697032.html) Amantadine — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a682064.html](https://medlineplus.gov/druginfo/meds/a682064.html)   Lab markers mentioned Hemoglobin A1C (HbA1c) test — MedlinePlus lab test: [https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/](https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/) Insulin in blood test — MedlinePlus lab test: [https://medlineplus.gov/lab-tests/insulin-in-blood/](https://medlineplus.gov/lab-tests/insulin-in-blood/)   People referenced (where the claims were mentioned) Huberman Lab (Dr. Andrew Huberman) — site: [https://www.hubermanlab.com/](https://www.hubermanlab.com/) Clip about low-dose tadalafil (2.5–5mg) — X post: [https://x.com/tbpn/status/2022350426394534334](https://x.com/tbpn/status/2022350426394534334) Bryan Johnson (Blueprint) — site: [https://blueprint.bryanjohnson.com/](https://blueprint.bryanjohnson.com/) Dr. David Sinclair (Harvard profile) — site: [https://sinclair.hms.harvard.edu/people/david-sinclair](https://sinclair.hms.harvard.edu/people/david-sinclair)   Show Notes   00:00 Welcome to the Hart2Heart Podcast. 01:56 What Cialis Is: PDE5 Inhibition, cGMP & Nitric Oxide Explained 03:43 Approved Uses & Origin Story: Pulmonary Hypertension, ED, and BPH 05:33 Why Cialis Over Viagra: 36-Hour Half-Life & 24/7 Vascular Benefits 06:52 Vascular Aging 101: Endothelium, Perfusion, and Why It Drives Disease 11:14 What the Human Data Shows: Observational Evidence for Mortality, CVD & Dementia 13:04 Mechanisms Deep Dive: Heart Protection, Heart Failure, and Anti-Atherosclerosis 15:02 Cialis for Diabetics: Lowering A1C and Improving Insulin Sensitivity 16:21 Brain Effects: Blood–Brain Barrier, Neurovascular Coupling & Dementia Potential 18:21 Safety, Who Should Avoid It, and Daily Longevity Dosing (2.5–5 mg) + Wrap-Up   The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to cutting through the noise and uncovering the most effective strategies for optimizing health, longevity, and peak performance. This podcast dives deep into evidence-based approaches to hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise protocols, leveraging sunlight, and de-prescribing pharmaceuticals — using medications only when absolutely necessary. Beyond health science, we explore the intersection of public health and politics, exposing how policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being. Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen). If you're ready to take control of your health and performance, this podcast is for you.We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect with Dr. Mike Hart Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart

In our news wrap Wednesday, the National Institutes of Health Director Dr. Jay Bhattacharya will serve as acting head of the CDC, the FDA reversed its decision to consider whether to approve a new mRNA flu shot from Moderna and billionaire Les Wexner told lawmakers he was "duped by a world-class con-man" as he faced questions about his association with Jeffrey Epstein. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Susan Dominus is a staff writer at the New York Times Magazine, a lecturer at Yale, and the author of The Family Dynamic: A Journey into the Mystery of Sibling Success. Her feature “Women Have Been Misled About Menopause” won the National Magazine Award and was the #1 gift-shared Times article of 2023. She was also a member of the Times team that won the 2018 Pulitzer Prize for Public Service. In this episode of The Breadwinners, host Rachael Lowell talks to Susan about how siblings shape our achievements and choices, inherited financial anxiety, knowing when to leave a job, and the value in not chasing every dollar. If you've ever tried to find the track and then realized you needed to make your own - this is for you. SHOW NOTES Susan Dominus: https://www.nytimes.com/by/susan-dominushttps://www.susanpdominus.comBook:The Family Dynamic: A Journey into the Mystery of Sibling Success Social:https://www.instagram.com/suedominushttps://www.linkedin.com/in/susandominus Croutons:  “Women Have Been Misled About Menopause” by Susan Dominus, Feb. 1, 2023 2018 Pulitzer Prize Citation - Public Service  Bio: Susan Dominus is a staff writer for The New York Times Magazine and the author of The Family Dynamic: A Journey into the Mystery of Sibling Success. In 2018, she was part of a team that won a Pulitzer Prize for public service for its reporting on workplace sexual harassment. She won a Front Page Award from the Newswomen's Club of New York and a Mychal Judge Heart of New York Award from the New York Press Club. She has studied as a fellow at the National Institutes of Health and Yale Law School. Her article about menopause in The New York Times Magazine won a National Magazine Award in 2024. She teaches journalism at Yale University.  *** "The Breadwinners" Season 7 is a joint production between Reworking Leadership and The Smart Friends Network, generously supported by Ruth Ann Harnisch. "The Breadwinners" was founded by Rachael Lowell and Jennifer Owens in 2019.Host: Rachael LowellExecutive Producers: Rachael Lowell, Rachel SklarAudio Engineer: Ron PassaroOriginal Music: "Perfect" by Hannah BakkeRick Snell: GuitarCesar Moreno: BanjoNyssa Grant: FiddleErik Alvar: BassJustin D. Cook: Keyboard, Percussion, and OrchestrationVocals: Hannah Bakke, Cassidy StonerHannah Bakke: Music and Lyrics To stay up to date with The Breadwinners, please follow us on Instagram: https://www.instagram.com/thebreadwinnerspodcast Find Rachael Lowell at https://reworkingleadership.com & take the SHIFT assessment here: https://leadtheshift.ai If you enjoyed this episode, please subscribe, rate, review & share! Thank you for listening. Still we rise! Learn more about your ad choices. Visit megaphone.fm/adchoices

Ryan Detrick, chief market strategist for the Carson Group, says that February and March could be "banana peel months" for the stock market to slip on, but he's not expecting a significant downturn and he says the underpinnings for the stock market will keep the bull market running through at least the end of the year. Detrick noted that the market has sent some mixed messages — with about 20% of stocks making 52-week highs while 6% made 52-week lows just last week — but he says that a strong economy with a dovish Federal Reserve can overcome geopolitical concerns, creating an environment where investors should be "overweight equities, but diversified around the globe." Dan Doonan, executive director for the National Institute on Retirement Savings, discusses their latest report, "Retirement in America: An Analysis of Retirement Preparedness Among Working-Age Americans," which has made headlines for suggesting that the average working American has less than $1,000 saved for retirement. Doonan is quick to back away from that number — because it includes the many Americans who have nothing saved and who aren't working to change that — but notes that while retirement balances are much higher for people who put in the effort, there remains a savings crisis in America.  Gil Baumgarten, founder and chief executive officer at Segment Wealth Management, brings his dividend-and-income focused approach to stock picking back to the Money Life Market Call.

Six years after the pandemic began, millions are still living with Long COVID. New research shows why recovery looks so different from person to person. Dr. Bruce Levy and Tanayott Thaweethai, Ph.D., of Mass General Brigham, speak with hosts Mark Masselli and Margaret Flinter about their National Institutes of Health-funded RECOVER study published in Nature […] The post Long COVID Latest: What are the Unique Patterns? appeared first on Healthy Communities Online.

It's Tuesday, February 17th, A.D. 2026. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Kevin Swanson and Timothy Reed 90,000 Nigerians displaced due to Islamic violence More than 90,000 Catholic Nigerians have been displaced in the Southern Taraba State since September 2025, reports International Christian Concern. According to the Catholic Diocese of Wukari, over 100 people have been killed and thousands more wounded in that same time frame. U.S. funds United Nations, Dept of Ed, and Nat'l Institutes of Health The Trump administration is still funding the United Nations.  President Donald Trump approved another $3 billion dollars to the international organization in early February, according to Reuters.  The U.S. has averaged $2.5 billion dollars of funding each year for the United Nations, over the last twenty years.  America joined the United Nations back in 1945, and is its largest donor.  And, despite vowing to close down the U.S. Department of Education during his campaign, the president has signed a government funding bill that will jack up the Education Department budget 2025 levels by $217 million for a total of $79 billion. That's $12 billion more than the administration's original request. Plus, the National Institutes of Health gets another increase of $415 million over Fiscal Year 2025. In total, $48.7 billion of taxpayer money will keep this bureaucracy alive and flourishing. Republican states take action to cut property taxes Several Republican-majority states are working to reduce and eliminate property taxes for citizens. North Dakota, Florida, Georgia, Indiana, and Texas have made progress. Plus, Tennesseans will consider a ballot measure this November to eliminate the property tax. Several states are also working to trim or fully end state income taxes, with nine states having zero income tax in 2026.  One-third of young women call themselves homosexual or transgender The Gallup polling organization released new numbers on Americans identifying with a list of sexual perversions.   Now, 9% of U.S. adults call themselves sexually perverted, up from 7% in 2023, and 3.5% in 2012. The increase has occurred with the younger generation primarily. Now, almost a quarter of 20-somethings and roughly one-third of young women call themselves homosexual or transgender. Also, 10% of the 30 to 49-year-olds claim these perverse identities. Transgender murderers kill at 10 times rate of general population As The Worldview reported on February 12, the mass murderer held responsible for perpetrating Canada's worst school shooting in recent history was a man pretending to be a woman, reports LifeSiteNews.com. Jesse Van Rootselaar killed his mother and seven others, and wounded 27, before killing himself in the massacre in a remote town in British Columbia. Another man pretending to be a woman, Robert Westman, was the perpetrator at the Annunciation Catholic School shooting last August. At least five other mass-casualty shootings are attributed to men and women attempting to change their gender. That includes the Aberdeen, Maryland Rite Aid shooting, the STEM School killings in Denver, Colorado, the Club Q massacre in Colorado Springs, Colorado, and the Covenant School massacre in Nashville, Tennessee. Also, the Iowa Perry High School perpetrator appeared to be pushing the transgender agenda. A recent study from National Review found that transgender suspects participate in mass shootings at a rate of 10 times that of the rest of the population. Alabama's Governor signs Child Predator Death Penalty Act Alabama Republican Governor Kay Ivey signed the Child Predator Death Penalty Act into law late last week, reports WVTM13.  This law assigns the death penalty to crimes of first-degree rape, first-degree sodomy, and first-degree sexual assault of victims under age 12. Biblical law assigns a serious penalty to those who kidnap or seize people against their will. Exodus 21:16 says, “Now one who kidnaps someone, whether he sells him or he is found in his possession, shall certainly be put to death.” Kansas governor vetoes law to keep boys out of girls spaces Kansas Democratic Governor Laura Kelly  vetoed a bill passed by the Kansas legislature that would have kept biological males out of women's bathrooms.  The bill would have prosecuted any men, pretending to be women, who trespass in women's spaces, on repeated offenses. Hopefully, the state legislature will override the veto, given that the Republican Party holds a two-thirds majority in both houses.   So far, 20 states have passed laws that ban men from invading women's spaces. Proverbs 17:13 reminds us, “Whoever rewards evil for good, evil shall not depart from his house.” Puerto Rico affirms value of human life from conception Puerto Rico Governor Jenniffer González-Colón  signed a bill that affirms the humanity and dignity of an unborn child, from the moment of conception.   Governor González-Colón said the bill “classifies as first-degree murder the intentional and knowing killing of a pregnant woman, resulting in the death of the unborn child at any stage of gestation within the mother's womb.” This was passed mainly for purposes of homicide and criminal law. While this personhood law does not automatically ban abortion outright in Puerto Rico, pro-lifers are hopeful it will pave the way for future legal protections of unborn babies. 47% of Americans think visitors from other planets have visited Earth  (theme from the movie E.T.) Interest in extraterrestrials and UFOs is at an all-time high in the United States. A “Yougov” survey found 47% of Americans believe extraterrestrials have visited the Earth. Former President Barack Obama says ET's probably exist. But he clarified on Instagram that, “I saw no evidence during my presidency that extraterrestrials have made contact with us.” Pokemon card sells for $16 million And finally, a trading card has netted the highest private sale amount in history.  A Pokeman card took in over $16 million over the weekend. That beats the last world record sale of a 1952 Mickey Mantle baseball card, which sold for $12.6 million in 2022. There were only 41 of this particular Pokemon card produced in 1998. That compares to 75 billion Pokemon cards printed in 2025. Pokeman is a game wherein the players play-act the harnessing of the power wielded by demons or monsters. Close And that's The Worldview on this Tuesday, February 17th, in the year of our Lord 2026. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ. Extra print stories United States military strikes ISIS in Syria The US military conducted strikes on more than 30 ISIS targets in Syria since the beginning of February.  According to US Central Command, or CENTCOM, the attacks "struck ISIS infrastructure and weapons storage targets with precision munitions delivered by fixed-wing, rotary-wing, and unmanned aircraft." CENTCOM Commander Brad Cooper said, “Striking these targets demonstrates our continued focus and resolve for preventing an ISIS resurgence in Syria. Operating in coordination with coalition and partner forces to ensure the enduring defeat of ISIS makes America, the region and the world safer."  More than 50 ISIS terrorists have reportedly been killed in the past couple of months by the United States military. Tensions remain high between the US and the Middle East, with all eyes on potential military action in Iran.  US House passes SAVE Act The U.S. House of Representatives passed the Safeguard American Voter Eligibility Act requiring those who vote in American elections to provide proof of citizenship. The bill passed 218-213, with every House Republican voting in favor of the measure. Texas Democrat Henry Cuellar also crossed the aisle to vote for the law. The law is touted by Republicans as a simple way to secure American elections and to eliminate cheating and foreign influence. Americans also overwhelmingly favor the requirement of a photo ID to cast a vote. However, the bill faces a hard road in the Senate, with Republicans holding only 53 seats, but needing 60 votes to pass the SAVE Act. Psalm 67:4 says, “O let the nations be glad and sing for joy: for thou shalt judge the people righteously, and govern the nations upon Earth.”

Join host Adam Lowther and guest Christopher Stone, a senior fellow at the National Institute for Deterrence Studies, as they delve into the intricacies of the National Defense Strategy (NDS) on this episode of NucleCast. Explore the critical debate around the perceived shift in American defense priorities, particularly the focus on Homeland Defense and its implications for global strategic dynamics. Christopher Stone offers a compelling argument against the notion of isolationism, emphasizing the enduring importance of strategic encirclement and the evolving geopolitical landscape. This episode provides a deep dive into the strategic considerations shaping U.S. defense policy, with insights into the roles of China, Russia, and other global players. Christopher Stone is a prominent figure in space policy, currently serving as a Senior Fellow for Space Deterrence at the National Institute for Deterrence Studies, where he focuses on research related to space warfare strategies and deterrence, particularly in the context of great power competition; he previously held a position as a Special Assistant to the Deputy Assistant Secretary of Defense for Space Policy at the Pentagon, giving him significant experience in the field of U.S. space policy development at a high level.Socials:Follow on Twitter at @NucleCastFollow on LinkedIn: https://linkedin.com/company/nuclecastpodcastSubscribe RSS Feed: https://rss.com/podcasts/nuclecast-podcast/Rate: https://podcasts.apple.com/us/podcast/nuclecast/id1644921278Email comments and topic/guest suggestions to NucleCast@anwadeter.org

What do the design of high-visibility public safety vests, the distance between two railroad tracks, and the protocols that allow for file transfers between devices have in common? Each is determined by a technical standard set through a process coordinated by a private, non-profit organization called the American National Standards Institute (ANSI). Technical standards are behind most of the products Americans interact with in everyday life, underpinning public safety, consumer protection, interoperability, and innovation. On this episode, host Megan Nicholson is joined by president and CEO of ANSI and former director of the National Institute of Standards and Technology, Laurie Locascio. Locascio explains the importance of standards for innovation and competitiveness, and describes how the US approach to standards development depends on the participation of people with all kinds of expertise. She also shares how more researchers can find their way into setting “the invisible infrastructure of modern life.” ResourcesRead ANSI's United States Standards Strategy 2025 and review their courses and webinars about the American national standard designation.  Check out the US government's 2023 National Standards Strategy for Critical and Emerging Technology, which has not been adopted by the Trump Administration. Read an Issues piece from 1999 on “Why Standards Matter” by Robert L. Mallett, former Deputy Secretary of Commerce.

This Day in Legal History: Wesberry v. Sanders On February 17, 1964, the U.S. Supreme Court decided Wesberry v. Sanders, one of the most consequential voting rights cases in American history. The dispute arose from Georgia's congressional districts, where vast population disparities meant that some districts had two or even three times as many residents as others. In practical terms, this imbalance diluted the voting power of citizens in more populated, often urban, districts. James P. Wesberry challenged the system, arguing that it violated Article I, Section 2 of the Constitution, which provides that members of the House of Representatives are chosen “by the People.”In a 6–3 decision, the Court agreed. Writing for the majority, Justice Hugo Black concluded that the Constitution requires congressional districts to be drawn so that “as nearly as practicable one man's vote in a congressional election is to be worth as much as another's.” The ruling established the principle of “one person, one vote” for federal elections. It rejected longstanding districting schemes that favored rural regions at the expense of growing urban populations. The decision forced states to redraw congressional maps to ensure substantially equal populations across districts.Wesberry was part of the broader reapportionment revolution of the 1960s, alongside cases addressing state legislative districts. Together, these decisions reshaped American democracy by making representation more closely tied to population equality. By insisting that each vote carry roughly equal weight, the Court strengthened the constitutional promise of representative government. February 17, 1964, marks a turning point in election law and the modern understanding of political equality.A federal judge in New York has ruled that discrimination claims brought by a group of NFL coaches will proceed in court rather than in arbitration. U.S. District Judge Valerie Caproni denied the league's request to compel arbitration, finding that the NFL's arbitration system was not fair or neutral. The lawsuit was filed by former Miami Dolphins coach Brian Flores, later joined by Steve Wilks and Ray Horton, who allege racial discrimination and retaliation in hiring practices. The case has been stalled for several years while the parties disputed whether it belonged in federal court or before an arbitrator.Judge Caproni relied heavily on a 2025 decision by the U.S. Court of Appeals for the Second Circuit, which concluded that the NFL's arbitration structure was fundamentally flawed. The appellate court criticized the system because the NFL commissioner served as the default arbitrator and controlled the procedures, raising concerns about neutrality. It held that such an arrangement did not allow Flores to effectively vindicate his statutory rights. Based on that reasoning, Judge Caproni determined that the arbitration clause could not be enforced for the remaining claims. She also declined to delay the case further while the NFL considers seeking review from the U.S. Supreme Court.The coaches argue that requiring them to arbitrate before the league's own commissioner would deprive them of a fair forum. Their attorneys praised the ruling, saying it affirms that employees cannot be forced into a process controlled by the opposing party's chief executive. The NFL has not publicly responded to the latest order. The case will now move forward in the U.S. District Court for the Southern District of New York.NFL Found To Fumble Arbitration Over Bias, Must Go To Court - Law360Ruling says Brian Flores lawsuit vs. NFL, teams can go to court - ESPNA Stanford psychiatry professor testified in a California bellwether trial that research supports the existence of social media addiction and its harmful effects on young people. Dr. Anna Lembke told jurors that peer-reviewed studies show heavy use of platforms such as Instagram and YouTube can contribute to depression, anxiety, insomnia, and suicidal thoughts. She cited a National Institutes of Health study tracking more than 11,000 minors, which found that children who were not initially depressed were more likely to develop depression after significant social media use. According to Lembke, the study undermines the argument that already-depressed teens simply gravitate toward social media.Her testimony contrasts with statements from Instagram's CEO, who told the jury he does not believe social media addiction is real. The case is the first of several bellwether trials arising from thousands of consolidated lawsuits claiming platforms intentionally designed addictive features. The companies are accused of using tools such as autoplay, notifications, and infinite scrolling to encourage compulsive use. The claims focus on whether these design features are addictive, rather than on third-party content posted by users. Plaintiffs assert negligence, failure to warn, and concealment.During cross-examination, defense attorneys questioned Lembke about passages in her book describing her own compulsive reading of romance novels, attempting to challenge her views on addiction. She responded that her examples were meant to show how modern systems increase vulnerability to compulsive behavior, not to trivialize serious substance addictions. Defense counsel also argued that platform features are easy to disable, but Lembke maintained her analysis centered on their addictive qualities, not on user settings. Outside the courthouse, families held a rally memorializing children whose deaths they attribute to social media harms. The trial will continue next week.Stanford Prof Tells Jury Studies Confirm Social Media Addiction - Law360In a piece I wrote for Forbes this week, I argue that the IRS's decision to expand tax relief for Americans held hostage abroad is both correct and incomplete. The agency currently freezes collections, halts enforcement notices, and abates penalties when taxpayers are physically incapable of complying due to foreign captivity. I contend that this relief is grounded not in diplomacy, but in a simple principle: incapacity makes compliance impossible. If that principle justifies relief abroad, it should apply equally when the U.S. government wrongfully detains someone at home.I explain that the IRS already has administrative authority to provide this type of relief, as confirmed in a recent Treasury Inspector General for Tax Administration report. When notified by the State Department or FBI, the IRS places a “hostage indicator” on an account, pausing automated enforcement and suspending penalties during captivity and for six months after release. Although TIGTA identified some administrative flaws in how the system operates, the broader framework demonstrates that the agency can act without new legislation.By contrast, taxpayers subjected to wrongful domestic detention—particularly in immigration contexts—receive no comparable safeguard. The compliance system continues to generate notices, penalties, and interest even when individuals are cut off from mail, income, and legal assistance. I argue that this disparity undermines fairness and weakens the legitimacy that voluntary tax compliance depends on. Congress may move to formalize relief for foreign hostages, but the IRS does not need to wait to address domestic cases.I propose that the agency adopt a parallel framework for wrongful domestic detention, triggered by certification from a federal authority or court. Such a system would temporarily suspend collection activity and abate penalties during detention and a reasonable transition period after release. The goal is consistency: a tax system should not distinguish between foreign and domestic incapacity when the result is the same inability to comply.IRS Suspends Tax Obligations For Hostages Abroad—Do The Same At HomeIn my column for Bloomberg this week, I argue that Massachusetts' proposed regulation on taxing standardized software creates a rigid and impractical apportionment system for multistate businesses. Under the draft rule, any company seeking to allocate tax based on actual in-state use must register through MassTaxConnect and obtain a software apportionment certificate. At the time of purchase, the buyer must also submit a transaction-specific statement explaining its allocation percentage and supporting rationale. I contend that this framework imposes significant administrative burdens on businesses that operate across multiple states.Even companies willing to overpay rather than calculate precise usage would not have an easy option. If they decline to complete the required documentation, they must pay tax on 100% of the purchase price, regardless of how little of the software is actually used in Massachusetts. I argue that this approach effectively turns multistate buyers into compliance agents who must track usage, justify percentages, and retain records for possible audits. At the same time, the Department of Revenue would assume the role of reviewing and policing each allocation.I point out that enterprise software usage is often fluid and difficult to track, especially when licenses are pooled, accessed remotely, or bundled into broader contracts. Proving precise state-by-state use may be costly or even unworkable. Instead of forcing every buyer into this detailed regime, I propose a safe harbor option. Businesses could elect a fixed in-state percentage, such as 25%, and accept taxation on that amount without additional paperwork or registration.I explain that this alternative would not eliminate full apportionment for those seeking precision or refunds, but would provide a simpler path for others. The safe harbor could even operate on a transitional basis while the state evaluates how the broader certification system functions. Ultimately, I argue that modernization should not mean added complexity, and that a fixed-percentage election would promote voluntary compliance, reduce administrative strain, and provide greater certainty for both taxpayers and the state. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

Sometimes when nothing else helps, playing baby white noise can be an effective tool to quickly calm a crying, colicky infant. When a baby is fussy, suffering from colic or not sleeping well, play this soothing white noise and watch them quickly settle down. Bring peace to your infant and to your household with this relaxing baby sleep sound.While playing white noise for babies, it's important to keep tabs on the volume, because any white noise machine, smartphone, or computer can put out levels that are too loud for your child. It's recommended to play the sound at least a few feet from where your infant is sleeping and to keep the volume no louder than the sound of a soft shower. Parents can download an app to turn their smartphone into a sound level meter. One good, free, option is the sound level meter app created by the U.S. National Institutes for Occupational Safety and Health (NIOSH) available on the app store as the NIOSH SLM app.This episode was originally published in 2021. This free episode may begin with a short ad, but once the sound starts, there will be no further interruptions or breaks.Here are some great products to help you sleep! Relaxing White Noise receives a small commission (at no additional cost to you) on purchases made through affiliate links. Thanks for supporting the podcast!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Baloo Living Weighted Blankets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (Use code 'relaxingwhitenoise10' for 10% off)At Relaxing White Noise, our goal is to help you sleep well. This episode is eight hours long with no advertisements in the middle, so you can use it as a sleeping sound throughout the night. Listening to our white noise sounds via the podcast gives you the freedom to lock your phone at night, keeping your bedroom dark as you fall asleep. It also allows you to switch between apps while studying or working with no interruption in the ambient sound.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Contact Us for Partnership Inquiries⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Relaxing White Noise is the number one destination on YouTube for white noise and nature sounds to help you sleep, study or soothe a baby. With more than a billion views across YouTube and other platforms, we are excited to now share our popular ambient tracks on the Relaxing White Noise podcast. People use white noise for sleeping, focus, sound masking or relaxation. We couldn't be happier to help folks live better lives. This podcast has the sound for you whether you use white noise for studying, to soothe a colicky baby, to fall asleep or for simply enjoying a peaceful moment. No need to buy a white noise machine when you can listen to these sounds for free. Cheers to living your best life!DISCLAIMER: Remember that loud sounds can potentially damage your hearing. When playing one of our ambiences, if you cannot have a conversation over the sound without raising your voice, the sound may be too loud for your ears. Please do not place speakers right next to a baby's ears. If you have difficulty hearing or hear ringing in your ears, please immediately discontinue listening to the white noise sounds and consult an audiologist or your physician. The sounds provided by Relaxing White Noise are for entertainment purposes only and are not a treatment for sleep disorders or tinnitus. If you have significant difficulty sleeping on a regular basis, experience fitful/restless sleep, or feel tired during the day, please consult your physician.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Relaxing White Noise Privacy Policy⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠© Relaxing White Noise LLC, 2026. All rights reserved. Any reproduction or republication of all or part of this text/visual/audio is prohibited.

In this episode of It's Going to Be Okay!, Nicky Asher-Bowling explores Acts chapter 2 and how the coming of the Holy Spirit empowers believers to overcome anxiety, depression, and fear.Peter didn't become bold because he felt confident — he became bold because he was filled with power.We discuss:• How Acts 2 applies to mental health• What the National Institute of Mental Health says about anxiety and depression• Why the Holy Spirit anchors — not erases — your personality• How to stop letting fear rule your life• The difference between confidence and spiritual empowermentIf you've ever waited to “feel better” before stepping forward, this episode will challenge and encourage you.The wind didn't create chaos.It created clarity.And it still does.Reach out to me via email nickyasherbowlingcoaching@gmail.comhttps://www.youtube.com/@nickyasherbowlingTyler Staton's book: The Famialiar Strangerhttps://a.co/d/02dDZxpCDiana Kokku https://www.biblestudy.co/bible-study-co

In this episode of It's Going to Be Okay!, Nicky Asher-Bowling explores Acts chapter 2 and how the coming of the Holy Spirit empowers believers to overcome anxiety, depression, and fear.Peter didn't become bold because he felt confident — he became bold because he was filled with power.We discuss:• How Acts 2 applies to mental health• What the National Institute of Mental Health says about anxiety and depression• Why the Holy Spirit anchors — not erases — your personality• How to stop letting fear rule your life• The difference between confidence and spiritual empowermentIf you've ever waited to “feel better” before stepping forward, this episode will challenge and encourage you.The wind didn't create chaos.It created clarity.And it still does.Contact me at nickyasherbowlingcoaching@gmail.comReferences:⁠Tyler Staton's book: The Famialiar Stranger⁠⁠https://a.co/d/02dDZxpC⁠Diana Kokku ⁠https://www.biblestudy.co/bible-study-co⁠

Play isn't a break from learning — it is learning. In this powerful conversation with Lauren and Mia Sundstrom — daughter and granddaughter of renowned play researcher Dr. Stuart Brown — we explore why play is practice for the future in a world that feels increasingly uncertain. From rough-and-tumble childhood experiences to teenage burnout, adult loneliness, brain health, and even leadership, this episode makes a compelling case that unstructured, self-directed play builds resilience, creativity, emotional regulation, and adaptability — the exact skills our kids (and we) will need in an AI-shaped world. If you've ever wondered whether play is “productive,” this conversation will change how you see your afternoons, your marriage, your parenting, and your own sense of joy. Learn more at nifplay.org and connect with Mia at miasundstrom.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Music is medicine. It has the power to heal us. And today's guest knows it's something we can self-prescribe, for free, whenever we want to benefit. Dr Daniel Levitin is a neuroscientist, cognitive psychologist and bestselling author. He's also a former record producer and an accomplished musician who's brought all those skills together in his latest book, Music As Medicine: How We Can Harness Its Therapeutic Power. As soon as I heard about it, I had to ask Dan onto the podcast to share his wisdom. As a lifelong musician and music fan, I know certain tracks change how I feel. But talking to Dan has opened my mind to just how profound an effect music has on the brain. It doesn't just shift our mood, it can affect our entire physiology. Dan has spent decades studying this, advising the US Government and working with the National Institutes of Health, to the point where his research is now influencing global health policy. We've all experienced the health-giving power of music, perhaps without realising. Now with that knowledge, and Dan's insights, we can start to put it to therapeutic use. Here's what fascinates me the most: music doesn't just hit one part of your brain. Different types activate different regions, in much the same way as certain medications work. And Dan shares some astounding examples of this – from the people with Parkinson's who relearn to walk, to the marathon runners who don't feel pain, to the Alzheimer's patients who can't recognise loved ones, but can recall how to play an instrument perfectly. The brain regions that process music are deeper, older and more protected. It's why music communicates emotion in ways that words can't always match. Throughout our conversation, Dan makes this case that music is our birthright. And it can flood us with feelgood, bonding hormones. So it's a tool we can turn to for overcoming trauma, processing difficult feelings, or connecting with others. But he doesn't just want us to listen. Playing an instrument, singing and songwriting all do more than you might expect – and you don't need to be an expert. The next time I'm strumming my guitar, I won't just think of it as a hobby. I'll know I'm doing something profoundly important for my health. And you can too. Whether it's learning an instrument, having a family singalong in the car, or simply switching on the radio, I'm not sure there's a simpler, more effective way to feel better.   Support the podcast and enjoy Ad-Free episodes. Try FREE for 7 days on Apple Podcasts https://apple.co/feelbetterlivemore. For other podcast platforms go to https://fblm.supercast.com.   Thanks to our sponsors: https://vivobarefoot.com/livemore https://onepeloton.co.uk https://thewayapp.com/livemore https://drinkag1.com/livemore   Show notes https://drchatterjee.com/623   DISCLAIMER: The content in the podcast and on this webpage is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or qualified healthcare provider. Never disregard professional medical advice or delay in seeking it because of something you have heard on the podcast or on my website.

It's been three full years since the Ohio state government decided to detonate derailed train cars containing vinyl chloride in the village of East Palestine.You might remember the apocalyptic imagery that came out of that explosion—it looked like a nuclear bomb had gone off.Three years later, anecdotal evidence is showing that the residents are experiencing thyroid disease, cancers, respiratory problems, neurological issues, asthma, and other problems.The National Institutes of Health (NIH) has now announced a $10 million research project to study the long-term health effects on the people living there.Let's review what took place there in 2023, what the effects appear to be now, as well as what the NIH is doing about it.

In this no-holds-barred interview, Dr. Jay Bhattacharya, director of the National Institutes of Health, breaks down how the world's largest public funder of biomedical research is changing under his leadership.Bhattacharya, a former professor of Stanford University, public health expert, and coauthor of the anti-lockdown Great Barrington Declaration, was sworn in as director of the NIH in April last year.With an annual budget of almost $50 billion, the NIH sets the direction of research at universities, medical centers, and research institutes across America.It encompasses 27 institutes and centers that cover different areas of health and employ some 20,000 people. One of those is the National Institute of Allergy and Infectious Diseases, which was headed by Dr. Anthony Fauci for nearly 40 years.The NIH, Bhattacharya told me, “really hasn't had a change in leadership in decades. ... We've had new directors, but the fundamental structure and direction of the NIH has been basically the same until last year.”Bhattacharya says his top priority is to end the practice of “funding the scientific enterprise for the sake of funding science” and ensure that NIH-funded scientific research actually produces better health outcomes for the American people. The goal should be improvements in health and longevity, not just more scientific papers, he says.During our interview, we covered a lot of ground, including:-Has the NIH completely stopped funding gain-of-function research?-Is the NIH continuing to fund research with China?-How has funding for international research institutes been restructured?-Has the NIH stopped funding all research grants related to diversity, equity, and inclusion initiatives?-What is being done to reverse the politicization of science?-What is the NIH doing to help those who suffered injuries from the mandated COVID-19 mRNA vaccines?-What can the NIH do to alleviate the massive replication crisis in research?-How does he view the controversy surrounding vaccines and autism? Is the NIH looking into potential links?-How is the NIH restructuring the allocation of funding?What America needs, Bhattacharya told me, is a “second scientific revolution,” saying: “The NIH has the capacity to induce that second scientific revolution. That's what I'm going to work toward for the next few years.”Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.

My guest tried to beat his alcohol addiction numerous times, but failed repeatedly. In this powerful episode, Matthew "Matt" McManus pulls back the curtains and transparently talks about his journey to sobriety, why he became an alcoholic, and what motivated him to change once and for all. If you are struggling with some sort of addiction, it is my hope that this episode gives you the motivation to keep fighting and striving to live the life you want to live. You and your loved ones deserve it.  The National Institute on Alcohol Abuse and Alcoholism has a page dedicated to finding resources to assist you on your journey to sobriety. SHOW NOTES: Links to Matthew McManus' LinkedIn profile and Facebook profile Link to Matt's "Pension Protectors" podcast Subscribe to my FREE weekly newsletter. It is called the "City Manager News & Job Board" newsletter and can be found here: https://cmnews.beehiiv.com/ AAME MEMBERSHIP: To join the American Association of Municipal Executives (AAME), sign up at this link: https://community.aame.org/ AAME JOB BOARD: The AAME has a free job board exclusively focused on executive and senior level local government recruitments. To post a job, go to: https://jobs.aame.org/ SUPPORT THE PODCAST: If you would like to support the podcast by making a donation, please use the "Buy Me A Coffee" link. Please rate and review the podcast on Apple or your preferred platform if you enjoy the show. It helps tremendously. But more importantly, refer your friends and peers to podcast through personal conversations and posts on your social media platforms. Joe Turner's LinkedIn Page Note: Page may contain affiliate links. As an Amazon Associate I earn from qualifying purchases.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: T1D in the Olympics & Superbowl, Trump RX goes live, Ozempic pill available soon, tech updates from Medtronic, Beta Bionics, Eversense 365 and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: We are just over one week from our first Moms' Night Out event of the year. While the plans are all set – the speakers, the vendors, the raffles and the fun is ready to go, it's always amazing how many people hear of these event last minute. That's fine, they're welcome! But if you're thinking of attending a future event – registration is open for We're going to Nashville next March 6-7 and Detroit in September – no need to wait. And we've got Club 1921 events for health care professionals and patient leaders in 6 cities this year! All the info is over at diabetes-connetionss.com events/   Okay.. our top story this week: XX Gotta be a quick shout out to some incredible T1D athletes – we had TWO in the super bowl this past weekend – Chad Muma of the New England Patriots and Logan Brown of the Seattle Seahawks AND there are at least two athletes with type 1 competing at the Winter Olympics. Hannah Schmidt competes in ski cross for Canada – she was diagnosed with Type 1 diabetes at age 12 years old.  Anna FarnSchadt Fernstäd a Czech skeleton racer diagnosed in 2022 after she'd already been to several Olympics. We wish them all the best!   https://english.radio.cz/skeleton-racer-anna-fernstadtova-overcoming-adversity-headfirst-down-ice-8876699 XX The government website TrumpRx.gov is live..  the website does not sell prescription drugs. Instead, it allows people to look up their drugs and then navigate to buy them elsewhere, either from a major drug company or a pharmacy. The 43 drugs listed on the site have prices ranging from $3 to over $5,500. TrumpRx does include warnings that the site may not be the best option to save money on prescriptions. Each product page advises: "If you have insurance, check your co-pay first — it may be even lower." For now, the website says its prices are for people paying with their own money, rather than going through insurance. The only insulin listed right now is Lilly's insulin lispro – and it's the same price as you'd find through Illy's insulin value program. I looked up diabetes meds.. For example, if you have an insurance co-pay of $25 a month for Farxiga, a drug often used for diabetes, you would be paying $182 on TrumpRx. As you can imagine, though ,this is complicated and as with most of our healthcare system, it may be good in some cases and not much help in other.  I'd suggest calling your local pharmacist or checking with your human resource dept. https://www.nytimes.com/2026/02/06/health/trumprx-prescription-drug-prices-consumers.html XX Novo Nordisk will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said the U.S. Food and Drug Administration has approved Ozempic tablets in three different doses. Novo says The new Ozempic name is intended to help patients and health care professionals more easily recognize the available treatment options for type 2 diabetes Semaglutide tablets have been available under the brand name Rybelsus Ruh BELL sis for diabetes since 2019 but with different dosing. The pill is also approved to reduce the risk of certain cardiovascular conditions in adults with type 2 diabetes who are at high risk for these events. The FDA had approved the new doses based on a bioequivalence study and the clinical trial data for Rybelsus, Novo said. https://www.reuters.com/business/healthcare-pharmaceuticals/novo-launch-ozempic-pill-diabetes-second-quarter-this-year-2026-02-04/ XX https://www.contemporarypediatrics.com/view/early-screening-for-type-1-diabetes-found-effective-in-children XX Possible new way to identify and track the progress of type 1 diabetes before clinical onset. A recent study published in Science Advances described the application of subcutaneous microporous scaffolds. These are inserted and have been shown to  identify changes in cancer, multiple sclerosis, and T1D by capturing changes of immune cells over the course of a disease. This is a proof of concept study in mice.. so very early days. https://www.news-medical.net/news/20260204/Implantable-immune-scaffold-predicts-type-1-diabetes-weeks-before-symptoms.aspx XX A large global genetics study shows that many key drivers of Type 2 diabetes operate outside the bloodstream. In a major international project led in part by the University of Massachusetts Amherst and Helmholtz Munich in Germany, researchers linked hundreds of genes and proteins to the disease. The work, published in Nature Metabolism, points to a key challenge in diabetes research: the biology behind rising blood sugar does not play out the same way in every part of the body. It also shows why including people from many backgrounds matters, since genetic clues that stand out in one population may be faint or invisible in another. Huge study, 2.5 million people worldwide comparing patterns across seven tissues tied to diabetes and four global ancestry groups, then asked a simple question: what do you miss if you only measure blood? Across the seven tissues, the researchers found causal evidence pointing to 676 genes. Yet overlap with blood was limited: only 18% of genes with a causal effect in a primary diabetes tissue, such as the pancreas, showed a matching signal in blood. At the same time, 85% of genetic effects observed in diabetes-relevant tissues were completely absent from blood-based analyses. The findings lay out a roadmap for future research aimed at understanding the biological pathways underlying Type 2 diabetes and developing more effective treatments. https://scitechdaily.com/massive-global-study-rewrites-the-biology-of-type-2-diabetes/ XX Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at lowering costs for patients, insurers and small pharmacies The settlement, first reported by Reuters, fits with that goal, and allows the FTC to pare down a case brought by the former Biden administration against Cigna's Express Scripts, UnitedHealth Group Inc's (UNH.N), Optum unit and CVS Health Corp's (CVS.N), CVS Caremark. The case against Optum and Caremark is ongoing. Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing practices. While the industry has already made reforms, the settlement gives the FTC power to enforce broader changes at Express Scripts. The 10-year agreement restricts Express Scripts' ability to engage in practices critics say contribute to high costs, like pocketing rebate payments from drugmakers based on the list price of drugs. The FTC estimates the agreement could save patients as much as $7 billion over a decade. https://www.reuters.com/world/cigna-settles-ftc-insulin-case-commits-overhauling-drug-pricing-2026-02-04/ XX Audio? Congress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone of Federal investment in type 1 diabetes (T1D) research. The President signed the legislation and it is now law. Extends the SDP through December 31, 2026, and increases funding from $160 million to $200 million annually. Strengthens overall funding for the National Institutes of Health (NIH) by $415 million. Increases diabetes research funding at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) by $10 million. Created by Congress and administered by the NIH, the SDP has contributed nearly $3.6 billion to T1D research and has played a role in nearly every major breakthrough in the field. A recent study conducted by Avalere Health shows that of the nearly 3.6 billion invested into the SDP by Congress since the establishment of the program, the Federal Government has realized $50 billion in healthcare savings through improved health outcomes from the use of SDP driven therapies and devices https://www.breakthrought1d.org/news-and-updates/congress-passes-bipartisan-extension-of-the-special-diabetes-program-securing-critical-t1d-research-funding/ XX Dexcom is rolling out what they're calling AI-enabled enhancements to Stelo, further transforming how users track and understand their glucose health. Expanded Smart Food Logging including a comprehensive nutrition database of more than 1M meals that provides a breakdown of calories, carbohydrates, protein, fat, dietary fibers, and more. More ways to meal track including text search, barcode scanning or taking a photo of the meal, creating a seamless and intuitive meal tracking solution. A redesigned Daily Insights feature which will introduce a new interface with more personalized recommendations. The newest features will launch nationwide in the coming weeks.  XX Beta Bionics has received a warning letter from the Food and Drug Administration following an inspection last year, the company disclosed on Friday. The diabetes technology company said in a securities filing that the warning letter concerns non-conformities with the company's quality management system, medical device reporting, and correction and removals. The warning letter has not yet been posted by the FDA.   The company said in the filing that it has already taken actions to improve the processes described in the warning letter, and it is working on a written response to the FDA.   The firm does not expect the warning letter to affect the planned launch of a new insulin patch pump by the end of 2027. Beta Bionics unveiled a prototype of the device, called Mint, last year at the American Diabetes Association's Scientific Sessions. The company also does not expect the warning letter to affect its financial results. https://www.medtechdive.com/news/beta-bionics-receives-fda-warning-letter/811140/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3A+2026-02-04+MedTech+Dive+%5Bissue%3A81423%5D&utm_term=MedTech+Dive&fbclid=IwY2xjawPwhDZleHRuA2FlbQIxMABicmlkETFaUUcyYmNQWldjZ2xudElic3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHouF8M3IstTyslPRgeHWUWVVdOAGOtzPWt_yNFcj9eYruqSPz3e86Iwcbpt8_aem_7q4D97vJVjHKfEwvoyUpgw XX Sequel Med Tech is reviewing co-founder Dean Kamen's ties to Jeffrey Epstein after recently released documents revealed new details about the longstanding relationship between the two men. The documents show that Kamen visited Epstein's island, and remained in contact with him for years after Epstein was convicted of sex crimes involving minors. Kamen has not been accused of any wrongdoing. In a statement, Sequel Med Tech said the Manchester-based company is aware of the documents pertaining to Kamen and – quote - "Sequel's Board of Directors has unanimously decided to engage an external law firm to review these disclosures and provide recommendations aligned with our mission to serve people living with diabetes," Kamen has not issued a statement regarding his reported connection to Epstein.   https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.nbcboston.com/news/local/nh-inventor-placed-on-leave-after-epstein-messages-surface-report-says/3888569/ XX Abbot reports 860 serious injuries linked to the recall of some of its glucose monitoring sensors. We told you about this recall late last year, these numbers are an FDA update.     Abbott said the sensors can provide incorrect glucose readings over extended periods, which could lead to users making dangerous treatment decisions, including eating excessive carbohydrates along with skipping or delaying insulin doses, potentially leading to serious health risks. The company said it has identified and resolved the cause of the issue, which relates to one production line among several that make Libre 3 and Libre 3 Plus sensors.   https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-recalls-glucose-sensors-after-seven-deaths-linked-faulty-readings-2026-02-04/ XX Updates from Medtronic & Senseonics – and a first from Nick Jonas.. right after this..   I'm excited to share that the FDA has cleared the MiniMed 780G system with the Instinct sensor, made by Abbott, for people with type 2 diabetes.  Medicare has also now approved coverage for the Instinct sensor for use with the MiniMed 780G system. This clearance and expanded coverage mean more people will have access to pairing our most advanced automated insulin delivery technology with the Instinct sensor, that offers a smaller, 15-day sensor experience.  They're also launching the MiniMed 780G system Pump Evaluation Program.  This program gives individuals living with diabetes the ability to try the full MiniMed 780G system at no cost for 30 days.† This includes the pump, the sensor of their choice, one month of infusion sets and reservoirs, everything but the insulin. They'll contact your doctor for you to get a prescription and get the process rolling. https://www.medtronicdiabetes.com/pump-evaluation-program XX Senseonics announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark approval – that's European clearance.  This comes on the heels of the launch of Eversense 365 with Sequel Med Tech's twiist pump, marking the first pump integration for the CGM. Senseonics plans to launch Eversense 365 in Germany, Italy, Spain and Sweden in the coming months. Meanwhile, Senseonics continues to work toward an FDA investigational device exemption (IDE) submission for its next-generation Gemini transmitter-less CGM by the end of this year. https://www.drugdeliverybusiness.com/senseonics-ce-mark-eversense-365-cgm/ XX A huge shout out to Dr. Emily Blum, who just accomplished riding 100 miles in Antarctica for Breakthrough T1D! Despite having no direct connection to Type 1 Diabetes, Emily has been riding and fundraising for BreakthroughT1D for 10 years now. She is an integral part of the Georgia Ride team, training and riding many miles, and most importantly has raised tens of thousands of dollars to support the cause of ridding the world of T1D. She is surgeon and deeply involved with medical innovation, with an incredibly busy schedule, but jumped at the chance to take on the challenge of riding a century on every continent. Having already completed North America, Europe, Australia, Asia, and now Antarctica, only Africa and South America remain. Emily rides on and continues to be an inspiration to everyone who meets her. XX   https://diabetes-connections.com/t1d-connection-and-people-magazine-elise-zach-share-their-story/ XX Nick Jonas's becomes the first artist ever to wear a CGM on an album cover - new upcoming solo album Sunday Best, releasing Feb. 6.  The release says: This marks a powerful step forward in normalizing diabetes and raising awareness for the condition on a global scale. This moment adds to the growing visibility of diabetes in pop culture, alongside milestones like a Type 1 diabetes Barbie and Pixar characters wearing diabetes technology.

In this episode of John Solomon Reports, we take a deep dive into the alarming vulnerabilities Americans face due to lax policies regarding China's influence in the U.S. John discusses the troubling emergence of secret police stations and bio labs in California and Las Vegas, raising serious concerns about national security and public health. He highlights the Biden administration's negligence in addressing these issues, including the dismantling of critical counterintelligence programs aimed at monitoring Chinese espionage in American academia.Joining John is Kash Patel, the director of the FBI, who provides exclusive insights into the discoveries made at a recently raided lab and reacts to the extradition of a suspect in the Benghazi attack. Patel emphasizes the importance of reinstating counterintelligence measures that were previously abandoned, shedding light on the ongoing threats posed by Chinese operatives.In the second segment, Dr. Jay Bhattachrya, director of the National Institutes of Health, shares his findings on the implications of gain-of-function research and its connection to the COVID-19 pandemic. John seeks answers on whether measures have been taken to halt such research and the status of the China Initiative.To lighten the mood, John introduces artist Scott Lobaido, who is advocating for a 150-foot American flag to be flown over Ground Zero, reminding listeners of the impact of the September 11 attacks and the need for national remembrance as we approach the 25th anniversary.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.